All posts by imreal

The Software Report Announces The Top 25 Software Product Executives of 2020


The Software Report is pleased to announce the Top 25 Software Product Executives of 2020. Some of the largest and most reputable software companies nominated their product heads. We were impressed with the number and caliber of candidates put forth. Each nominee was evaluated across a number of categories including product track record, breadth of capabilities, leadership and promoting a positive working environment among other factors. The Software Report also conducted candidate evaluation based on company competitiveness within the broader software industry and how the individual compared to the most exceptional executives.

While it is more common to see and hear from a company’s CEO, product executives are frequently the linchpins of an organization. They play a critical role in a company sustaining its competitiveness in the market and achieving its higher ambitions while ensuring existing and new customers are consistently experiencing success with their software solution.

Congratulations to The Top 25 Software Product Executives of 2020! The complete feature article can be read here: http://www.thesoftwarereport.com

Some of this year’s most notable awardees include: Anamita Guha of IBM, Bret Taylor of Salesforce, Sanga Viswanathan of Oracle, Akshay Bhargave of Malwarebytes, Burley Kawasaki of K2, Greg Genung of Deepwatch, and Andrea Kowalski of Kareo.

About The Software Report

The Software Report is a leading source for market research and insights, corporate activity, product information, executive news and business happenings related to the software sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on software and the various companies, executives and investors that make up the sector. http://www.thesoftwarereport.com

Share article on social media or email:

Nashville-based Nephrology Associates Welcomes Its Newest Nephrologist, Dr. Michael Coleman Jr.


News Image

“Patient-centered care is at the core of all we do and we’re excited for Dr. Coleman to utilize his skills to assist us in our continued commitment to expand our patient services in the Middle Tennessee area.” – Dr. Ashish Soni, President of Nephrology Associates

Nashville-based Nephrology Associates, P.C. proudly welcomes Michael Coleman Jr., M.D. as its newest nephrologist, effective July 6, 2020. Dr. Coleman is glad to return to the Middle Tennessee area where he initially began practicing nephrology over two decades ago, having finalized both his fellowship and residency at Vanderbilt University Medical Center in Nashville. He earned his medical degree from The University of Texas Southwestern.

“Patient-centered care is at the core of all we do and we’re excited for Dr. Coleman to utilize his skills to assist us in our continued commitment to expand our patient services in the Middle Tennessee area,” stated Dr. Ashish Soni, Nephrology Associates President.

Dr. Coleman will primarily provide chronic kidney disease management services and all dialysis treatment modalities for patients at St. Thomas Midtown, as well as Centennial Medical Center and surrounding dialysis clinics throughout the Nashville area. His office can be reached at (615) 329-5072 or visit http://www.tnkidney.com to schedule an appointment.

Nephrology Associates, PC is a leading provider of renal care for all aspects of kidney disease and related conditions. Founded in 1985, Nephrology Associates is the largest nephrology practice in the Nashville community and has established a tradition of excellence in helping patients achieve their highest level of independence, while managing their disease process. As the recipient of the 2019 RPA Exemplary Practice of the Year Award, Nephrology Associates’ dedication to excellence is evidenced by the credentials of its 30 physicians who serve in a variety of office-based and acute care settings as well as on an array of hospital committees including managed care, critical care, nutritional support and ethics. Nephrology Associates understands well that quality of care is key for every patient and is dedicated to providing comprehensive, holistic and personalized care for its patients. To learn more about Nephrology Associates, visit http://www.tnkidney.com.

Share article on social media or email:

ENOF Launches New Organic Vegetable Powder


News Image

ENOF is a revolutionary product that provides up to 60% of the daily recommendation of key vitamins using real, organic vegetables that can be added to any food.

We know that ENOF can have a positive impact on health and wellness and can improve the health outcomes for both children and adults.

Eating the recommended number of servings of vegetables every day can be a challenge for anyone, especially picky eaters and kids. ​ENOF has responded to that challenge with its revolutionary product that provides up to 60% of the daily recommendation of key vitamins using real, organic vegetables that can be added to any food.

ENOF​ is a new product produced in the United States containing organic vegetable nutrition that is sprinkled onto, or​ ​mixed into, other food or drinks. Made using an innovative technology that traps the phytonutrients in organic spinach, broccoli, carrots, tomatoes, beets and shiitake mushrooms while they undergo a freeze-drying process, ENOF is ​packed with great, whole-food based nutrition​. To create ENOF, nutrients are concentrated from vegetables to such a degree that only a tiny amount (when mixed into other foods, the taste is virtually undetectable) provides the nutritional equivalent of eating 2.5 servings of fresh vegetables.

ENOF was born out of necessity. Mark Gillis and his wife were struggling with their youngest daughter when it came to meal time, specifically getting her to eat vegetables. After developing ENOF as a personal solution to Gillis’s own problem, the decision to launch a business to make the same solution available to others dealing with similar issues seemed like a risk worth taking.

“We believe that this product can make a dramatic difference in the lives of countless individuals,” said Mark Gillis, founder of ENOF. “We know that ENOF can have a positive impact on health and wellness and can improve the health outcomes for both children and adults. We have received ​tremendous feedback​ on how ENOF is being integrated into families’ meals and lives.”

ENOF is different from other vitamin supplements – it is actual food. Vitamin pills, gummies and capsules are traditionally made from isolated nutrients that might be extracted from food sources or, as is more often the case, synthetically derived. ​ENOF​ is fundamentally different – it is made entirely from vegetables and retains most of the phytonutrients found in these vegetables.

ENOF is available for sale online at ​https://simplyenof.com​ and can be ​purchased​ in sample sizes, a 1-month supply, a 3-month supply, and a 6-month supply.

Follow ENOF

https://www.facebook.com/SimplyEnof

https://www.instagram.com/enofnutrition/

https://twitter.com/SimplyEnof

Share article on social media or email:



Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain


News Image

Combined with Absolute Antibody’s unique antibody engineering approach, we can harness even more potential from the nanobodies and help scientists worldwide fight against the COVID-19 pandemic.

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19. Under the partnership, the original nanobodies and newly engineered formats are now available to the global research community for use as serological controls and in COVID-19 therapeutic development. The synthetic nanobodies possess particular promise for the development of inhalable drugs, which could offer a convenient treatment option for the COVID-19 pandemic.

Nanobodies are small antibody fragments that can reach previously inaccessible parts of the body due to their compact size. Researchers are exploring their potential as inhalable COVID-19 drugs, which would be easier to administer and reach patient’s lungs faster than other treatment formulations. The laboratory of Markus Seeger at University of Zurich developed a rapid in vitro selection platform to generate synthetic nanobodies, known as sybodies, against the receptor binding domain (RBD) of SARS-CoV-2. Within a two-week timeframe, the lab had identified more than 60 unique anti-RBD sybodies from combinatorial display libraries.

Further research showed that six of the sybodies bound SARS-CoV-2 spike protein with very high affinity, while five of those also inhibited ACE2, the host cell receptor to which SARS-CoV-2 binds to initiate the COVID-19 infection. Moreover, two of the sybodies can simultaneously bind the RBD, which could enable the construction of a polyvalent antiviral drug. The SARS-CoV-2 sybodies are therefore valuable tools for coronavirus research, diagnostics and therapeutic development, and the panel is now available to researchers worldwide via Absolute Antibody’s online catalog.

Absolute Antibody recombinantly produces the SARS-CoV-2 synthetic nanobodies for ensured batch-to-batch reproducibility, high purity and low endotoxin levels. In addition, Absolute Antibody has used antibody engineering to fuse the nanobodies to Fc domains in different species, isotypes and subtypes. For example, the anti-RBD binders are now available with human IgG1, IgG3, IgM and IgA domains for use as serological controls. These recombinant engineered antibodies extend the applications of the sybodies by varying effector function and permitting increased half-life in in vivo studies.

“We are excited to partner with the Seeger lab to make their novel synthetic nanobodies more widely available to the research community,” said Dr. Michael Fiebig, Vice President Product Portfolio & Innovation at Absolute Antibody. “Combined with Absolute Antibody’s unique antibody engineering approach, we can harness even more potential from the nanobodies and help scientists worldwide fight against the COVID-19 pandemic.”

“The global research community has been working at unprecedented speeds to fight COVID-19,” said Dr. Markus Seeger, Professor at the Institute of Medical Microbiology of the University of Zurich. “By partnering with Absolute Antibody, we have extended the reach and applications of our new synthetic nanobodies, furthering their potential in the race to develop urgently required therapeutics.”

In addition to the new synthetic antibodies, Absolute Antibody offers a variety of other engineered reagents for coronavirus research, including SARS-CoV-2 spike glycoprotein and nucleoprotein antibodies, ACE2 Fc fusion proteins, and anti-human immunoglobulin antibodies for use in diagnostic tests. Absolute Antibody is also supporting coronavirus research by providing antibody engineering and manufacturing services, such as the production of gram quantities of human antibodies sequenced from recovering COVID-19 patients.

For more information, and a full list of available synthetic nanobodies and engineered antibodies, please visit our website here.

About Absolute Antibody, Ltd.

Absolute Antibody is a rapidly growing company with a vision to make recombinant antibody technology accessible to all. We offer antibody sequencing, engineering and recombinant production as custom services, as well as a unique catalog of recombinant antibodies, engineered into new and useful formats. Learn more here.

About University of Zurich

The University of Zurich (UZH) is a member of the League of European Research Universities and numbers among Europe’s most prestigious research institutions. UZH’s international standing is reflected in the many renowned academic distinctions conferred upon its members, including twelve Nobel Prizes. As Switzerland’s largest university, UZH has a current enrollment of over 26,000 students and offers the most comprehensive academic program in the country. Over 5,000 excellent members of staff teach and perform research at one of the University’s 150 departments, including over 675 professors. UZH also looks back on a rich history, having been founded in 1833 as Europe’s first university to be established by a democratic political System. The research group of Markus Seeger is located at the Institute of Medical Microbiology. For more information please visit http://www.uzh.ch and http://www.imm.uzh.ch/de/research/experimental/teamseeger.html.

Contact:

Lisa Merolla    

Director of Marketing

+1 617-377-4057 (extension 610)

l.merolla@absoluteantibody.com

###

Share article on social media or email:

The Radiosurgery Society® Launches 2020 RSS Virtual Scientific Meeting


To register, visit www.rssmeetings.org.

It is with much gratitude and appreciation to the speakers and presenters that the RSS is able to provide an on-demand format to educate and disseminate the latest research and scientific advancements in the field of SRS/SBRT and advancing therapies to the global community.

The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, today announced the start of its 2020 RSS Virtual Scientific Meeting. On demand access to the virtual meeting is available to registrants from June 22-December 31, 2020 at http://www.rssmeetings.org.

This year’s meeting will feature access to more than 100 video presentations and electronic posters on stereotactic radiosurgery, stereotactic body radiotherapy and advancing therapies, and feature leading experts in radiation oncology, immunotherapy, neurosurgery, medical physics, and medical oncology from around the world. Registration fees include access to all online sessions and maximum of 23.25 CME/CE credits, along with a complimentary GRID/Lattice, Flash and Microbeam radiation therapies virtual session. To view the 2020 RSS Virtual Meeting Program please visit http://www.rssmeetings.org.

“Due to the COVID-19 pandemic and to protect the health and well-being of meeting attendees and staff, we decided to transition the scheduled in-person 2020 Radiosurgery Society Scientific Meeting to an on-demand virtual meeting. It is with much gratitude and appreciation to the speakers and presenters that the RSS is able to provide an on-demand format to educate and disseminate the latest research and scientific advancements in the field of SRS/SBRT and advancing therapies to the global community,” commented Joanne N. Davis, Ph.D., Executive Director, The Radiosurgery Society. “We are very pleased to work with the Developmental Therapeutics Program and Radiation Research Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute, part of the National Institutes of Health to co-sponsor the virtual meeting session Immunology, Immunotherapy and Radiation Oncology, with the goal of educating multi-disciplinary groups on the science of immunotherapy, stereotactic radiation therapy and clinical trial design, and to inspire future working groups and combination clinical trials.”

Abstracts and electronic posters from the meeting are available on the Radiosurgery Society Channel on The Cureus Journal of Medical Science at http://www.cureus.com/channels/theRSS.

This year’s 2020 RSS Virtual Meeting kicked off with two free Showdown Debate webinars: “SBRT for Ultra-Central Lung Tumors,” presented by Gregory Videtic, M.D., Alexander Louie, M.D., Ph.D., and Percy Lee, M.D. held live online on June 9, 2020, and “SBRT vs Brachytherapy for Prostate Cancer,” presented by Glenn Bauman, M.D., Andrew Loblaw, M.D., Shankar Siva, Ph.D., M.B.B.S., F.R.A.N.Z.C.R., and Debra Freeman, M.D., held live on May 26, 2020. Archived videos of these Showdown Debates are available to registrants of the 2020 RSS Virtual Meeting.

The 2020 RSS Virtual Scientific Meeting has been planned and implemented by Amedco LLC and the Radiosurgery Society, enabling participants to receive Continuing Education credits. Amedco LLC designates this live activity for a maximum of 23.25 AMA PRA Category 1 Credits for physicians and 23.25 contact hours for nurses. For Physicists, the virtual meeting has been submitted to the Commission on Accreditation of Medical Physics Education Programs, Inc., and for dosimetrists, his activity has been approved for 23.25 continuing education credits by the Medical Dosimetrist Certification Board.

For more information or to register for the 2020 RSS Virtual Scientific Meeting, go to http://www.rssmeetings.org. Members of the RSS will receive a discount on registration.

About The Radiosurgery Society®

The Radiosurgery Society (RSS) – a non-profit, independent, multi-disciplinary organization of surgeons, radiation oncologists, physicists, and allied professionals, who are dedicated to advancing the science and clinical practice of radiosurgery. Originally formed in 2002 and becoming (501c6) in 2008, the Radiosurgery Society today (http://www.therss.org) represents approximately 600 members who perform stereotactic body radiotherapy and radiosurgery in hospitals and freestanding centers throughout the world.

Share article on social media or email:

Coveo Appoints Nicholas Goode as Chief Corporate Development Officer


“Our company’s trajectory has been fueled by tremendous demand for our solution from industry leaders, and Nicholas’ appointment sets us up for our next phase of growth.” – Coveo CEO and Chairman Louis Têtu

Coveo, a leader in AI solutions for intelligent search and experience intelligence, announces today that Nicholas Goode will now serve as Chief Corporate Development Officer to assist with corporate strategy and M&A activities as the company continues its rapid growth and expansion in the market.

“We’re very excited to bring Nicholas on board,” Coveo Chairman and CEO Louis Têtu said. “This move will ensure that Coveo continues to set and execute world-class strategic direction as we expand into new markets and explore new opportunities for experience intelligence across ecommerce, service, the workplace and beyond.”

The Coveo Experience Intelligence Platform uses intelligent search, artificial intelligence, and recommendation technologies to personalize digital experiences. By stitching together content and data from across the enterprise, Coveo clients deliver world class experiences enterprise-wide to customers, channels and their own teams.

Goode will focus on identifying trends in the marketplace, monitoring the competitive landscape for strategic insights and uncovering opportunities for innovation and growth. He will also examine new approaches to markets, as well as perform quantitative analysis around opportunities for line-of-business development, geographic expansion or strategic acquisitions.

Goode commented: “The current market environment is making a number of companies very attractive from an investment point of view. I was fully supportive of backing Coveo as an investor to equip the fastest growing leader in the space with a war chest, and I’m even more excited to join the executive team to help Coveo be a consolidator in the sector.”

Prior to joining Coveo, Goode was a Principal at Evergreen Coast Capital, the Menlo Park-based private equity firm and investor in Coveo. While at Evergreen, Nick helped oversee the firm’s existing investments, and identified, evaluated and executed new acquisition and investment opportunities, including the firm’s prior investments in Coveo.

“It is our firm belief that, beyond digital presence, every company now needs to be an experience intelligence leader – and Coveo is one of the only companies that enables every business to gain the abilities of the tech-first goliaths. Our company’s trajectory has been fueled by tremendous demand for our solution from industry leaders, and Nicholas’ appointment sets us up for our next phase of growth,” Têtu added. “We’re looking forward to welcoming Nicholas to our leadership team.”

About Coveo

Coveo enables enterprises to thrive in the experience age powered by data and AI, through delivering unique experiences that are relevant, unified, and valuable across commerce, service and the workplace. The Coveo Experience Intelligence Platform uses intelligent search, AI, and recommendation technologies to personalize billions of digital experiences for customers, partners, and employees, for many of the world’s most admired digital experience leaders. Coveo delivers solutions built on the Coveo Experience Intelligence Platform, with Coveo-accredited partners, and through Alliances with Salesforce, ServiceNow, Sitecore, AppDirect, and more.

Learn more at coveo.com.

Share article on social media or email:

FrontStream and MoveSpring Join Forces to Power the American Cancer Society’s Corporate, Virtual Fitness Fundraising Event, the Fit2Be Cancer Free Challenge


FrontStream

“We are excited to partner with MoveSpring to power the American Cancer Society’s Fit2Be Cancer Free Challenge and look forward to a successful event,” said Terry LoPresti, chief technology officer, FrontStream.

FrontStream, the leading provider of a complete suite of products that empower registered nonprofit organizations and socially responsible corporations to raise more funds securely and easily for causes that effect positive change, and MoveSpring, an industry leader in employee health and wellness solutions, today announced that they are joining forces to support corporate giving and drive donations toward the fight against cancer.

FrontStream and MoveSpring teamed up to create an intuitive mobile application experience to power the American Cancer Society’s virtual fitness fundraising campaign, the Fit2Be Cancer Free Challenge. The virtual event takes place July 16 through August 6, 2020 and invites CEOs and their employees at organizations across the U.S. to join a company-wide step challenge to support and raise funds for cancer awareness and prevention. With notable registered organizations including Deloitte, Best Buy and McKesson Corporation, the virtual Fit2Be Cancer Free Challenge is expected to attract nearly half a million participants.

“Cancer is the second leading cause of death in the U.S., with 1.8 million new cases expected in 2020. Our goal with the Fit2Be Cancer Free 2020 Challenge is not only to raise funds and awareness around cancer prevention, but also to encourage physical activity and wellness in the workplace, wherever that may be,” said Gary Reedy, chief executive officer at the American Cancer Society. “We are excited to partner with FrontStream and MoveSpring to provide a seamless mobile experience for participants.”

The Fit2Be Cancer Free mobile app, created by MoveSpring and powered by FrontStream’s secure donation technology, syncs with leading fitness trackers and smartphones, enabling real-time activity tracking to drive participant engagement. After a company registers for the event, employees can then download the MoveSpring mobile app from the Google Play or App Store and create an account. Within the app, participants can compete together in a virtual race that takes them through the history of cancer, unlock fun surprises, engage with educational content on cancer prevention and connect with a supportive community, all while raising money for the cause.

“Virtual fitness fundraising events offer a unique opportunity for corporations to both promote health and wellness as well as boost employee engagement and unity, especially as companies expand work-from-home options due to COVID-19-related health concerns,” said Terry LoPresti, chief technology officer, FrontStream. “For nonprofits, virtual fundraising is becoming an innovative technique that enables them to move their missions forward quickly and efficiently. We are excited to partner with MoveSpring to power the American Cancer Society’s Fit2Be Cancer Free Challenge and look forward to a successful event.”

“With the stress of current events and more of us working from home, making time for physical activity has never been more important,” said Anthony Knierim, co-founder and COO, MoveSpring. “It’s rewarding to work with mission-focused organizations that recognize how activity impacts employee productivity and engagement and provide employees with resources needed to make health and fitness fun and accessible.”

Over the last year, FrontStream and MoveSpring have worked together to support activity-driven virtual fundraising. Together, the two companies provide multiple virtual fundraising solutions, including corporate giving solutions that promote health and wellness, energize employee engagement and support corporate social responsibility (CSR) initiatives. Real-time activity tracking virtual fundraising events available through FrontStream’s robust Panorama platform make giving fun and provide the gamification needed to drive participant engagement and donations.

To learn more about how FrontStream and MoveSpring are powering the American Cancer Society’s Fit2Be Cancer Free Challenge, or to register your organization to participate in the challenge, please visit: https://movespring.com/acs-fit2be.

About FrontStream

FrontStream is mission-focused on helping registered nonprofits and corporations raise more funds for causes that effect positive change. Its complete suite of products includes Panorama, an all-in-one digital fundraising platform for managing, planning, processing and promoting fundraising events. Auctions created in Panorama are deployed and hosted on BiddingForGood, the nonprofit industry’s top donor destination site for participating in auctions happening right now. FrontStream’s fully integrated PCI level 1 compliant payment processing platform securely processes billions of dollars in transactions annually. More than 100,000 charities in North America have used FrontStream to power their digital fundraising efforts. To learn more about FrontStream visit https://www.frontstream.com/ and follow on Twitter @FrontStream.

About MoveSpring

MoveSpring is an out of the box, thought leader in health activation and engagement. With their industry leading mobile and web apps they partner with organizations across the globe to create easy-to-use, highly engaging social health communities that both organizers and users love. With MoveSpring, it’s easier than ever to make fitness fun for everyone.

Share article on social media or email:

RadSite Announces Complimentary Webinar Showcasing How Imaging Providers and Employers Are Responding to COVID-19


News Image

“Employers are addressing the COVID-19 pandemic head on with a variety of strategies to help ensure that employees and their families remain safe as companies head back to the workplace,” notes Michael Thompson, President & CEO for the National Alliance of Healthcare Purchaser Coalitions

RadSite™, a leading accreditation organization promoting quality-based imaging practices, is spotlighting how the coronavirus pandemic is impacting imaging providers and other key stakeholders. To register for the informative webinar, click here.

“Since the arrival of the coronavirus in the U.S. earlier this year, prevention strategies have varied in the states in terms of how to mitigate the severe acute respiratory syndrome,” notes Mark Casner, RadSite’s Accreditation Committee chair. “This webinar will feature several national thought leaders addressing how the pandemic is impacting patient care at imaging providers and how employers are responding to crises.”

“Employers are addressing the COVID-19 pandemic head on with a variety of strategies to help ensure that employees and their families remain safe as companies head back to the workplace,” notes Michael Thompson, President & CEO for the National Alliance of Healthcare Purchaser Coalitions. “We’ll share insights on best practices and resources to aid in this transition.”

“Patient safety is our top priority—both before and after the pandemic,” notes Charlies Shaw, RadNet SVP Healthcare Network Strategy & Business Development. “It is imperative to the healthcare delivery system that imaging providers like RadNet take precautions to keep the exam rooms safe to allow much needed diagnostic exams to continue. In addition to preventing the spread of the virus, we also need to ensure that medical imaging continues for the millions of Americans that have ongoing or new medical conditions that need to be treated.”

Impact of COVID-19 on Imaging Providers

July 15, 2020

2 p.m. to 3 p.m. ET

This webinar will feature an overview of how the coronavirus pandemic is impacting imaging providers and other healthcare professionals. The speakers will address how medical practices, hospitals, employers and others are ensuring a safe and productive workplace for patients, providers, employees and others.

Moderator: Mark Casner RadSite Chair, Accreditation Committee

Speakers:

  • Charlie Shaw, RadNet SVP Healthcare Network Strategy & Business Development (imaging provider)
  • Michael Thompson, President & CEO, National Alliance for Healthcare Purchasing Coalitions (employer perspective)
  • Phil Patton, PhD RadSite Chief Physicist Officer (physicist perspective)
  • Eliot Siegel, MD, RadSite Medical Director (hospital perspective)

Click here to learn more about this webinar and to register. Click here to learn more about RadSite’s other webinars.

RadSite offers comprehensive, affordable, quality-based accreditation programs that evaluate imaging providers on established industry standards, regulatory requirements and best practices. Working with health plans and their participating providers also helps raise imaging standards through meaningful imaging quality and patient safety protocols. To learn more about RadSite, visit http://www.radsitequality.com.

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite’s programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email:

Phoenix Technology Group Launches Portable Hand-Held Retinal Imaging Camera


The ICON GO camera empowers physicians to bring retinal imaging closer to patients in multiple locations outside of the treatment hub, which enables us to effectively deliver care to more patients without requiring the patients to travel to a central location.

Today, Phoenix Technology Group LLC (Phoenix), a leading provider of advanced ophthalmic imaging solutions, announced the release of the Phoenix ICON™ GO camera, a portable hand-held, wide-angle retinal imaging system. The new addition to the Phoenix ICON series bolsters the company’s reputation for delivering stunning high-resolution, high-contrast retinal images on both light and dark retinas, and now enables transportability to service a wide array of clinical sites including satellite hospitals, critical care facilities and remote areas.

The ICON GO camera employs the same breakthrough image quality mastered by the Phoenix ICON™ cart-based imaging system while meeting demanding healthcare information security requirements. The ICON GO camera integrates smoothly with healthcare information systems with built-in DICOM features and pairs easily with teleophthalmology platforms. Like its cart-based sibling, the Phoenix ICON GO camera supports imaging on battery for up to 6 hours, requires minimal training and comes standard with a two-year warranty.

In response to the launch of the Phoenix ICON GO, Phoenix Technology Group Clinical Advisory Board member Dr. R.V. Paul Chan states, “Phoenix brought revolutionary imaging solutions to hospitals and clinics around the world with its cart-based system. The ICON GO camera empowers physicians to bring retinal imaging closer to patients in multiple locations outside of the treatment hub, which enables us to effectively deliver care to more patients without requiring the patients to travel to a central location. Additionally, the photo documentation can help enhance patient-physician engagement, physician-staff engagement, adherence to follow-up exams, and remote patient monitoring through telehealth services.”

With the release of the ICON GO camera, Phoenix has introduced new features to make patient-to-patient infection control easier by adding support for a built-in infection control audit log that pairs with new disinfection hardware added to the camera holster.

“Today’s intensive care teams and ophthalmologists need greater flexibility without compromising on performance,” said J. Scott Carr, chairman and CEO of Phoenix. “With the release of the Phoenix ICON GO camera they can manage more patients in more locations. Now a single hospital system can acquire a Phoenix ICON GO to enable their ophthalmologists, photographers and nurses to use it in different sites throughout their network. In essence, the camera follows the imager wherever he or she needs to go and reduces the need for the patient to be transferred. This alleviates challenges for the family, for the patient, and simplifies care in normal times but even more so during fraught times like we’re facing today.”

The Phoenix ICON GO is in already in production and available in the United States and Europe, and will be available soon in the more than 70 countries served by the Phoenix global distribution network. For more information, visit phoenixtech.com/phoenix-icon.

About Phoenix Technology Group: Phoenix Technology Group empowers people to see: we empower researchers to see more in their fight to prevent blindness; we empower clinicians to see more in their fight to save sight. We do that by providing clinicians and researchers around the world with stunning retinal images, coupled with timely and accurate data about the retina and the eye. Founded by Bert Massie, Ph.D., inventor of the first digital camera for pediatric retinal imaging, our company created the Phoenix MICRON™ platform for in-vivo imaging of animals in eye research. Phoenix MICRON is the standard of excellence for researchers worldwide: ten of the top twelve research institutions employ a Phoenix MICRON solution. In 2017, the company launched to great acclaim the Phoenix ICON™ platform which reinvented wide-field retinal imaging for human clinical applications. Phoenix ICON delivers stunning high-contrast, high-resolution images, with quality you can see and data you can trust. Recognizing that telemedicine is the future of retinopathy of prematurity (ROP) screening, in 2018, Phoenix launched the Phoenix CONNECT™ platform, which today is the most widely adopted telemedicine platform for ROP screening. The CONNECT platform connects the nursing, ophthalmology, and neonatology teams to enable delivery of the best care by facilitating timely expert screening of babies in any NICU. And, the platform implements a proven screening workflow that generates critical photo documentation to enhance treatment determination and reduce risk.

Share article on social media or email:

The PAINWeek 2020 National Conference Goes Virtual, September 11-13


News Image

The need for pain education is not on hiatus. Patients need us now more than ever to help them negotiate pain and suffering.

Due to COVID-19, PAINWeek 2020 will be presented as a live virtual event, September 11-13. Frontline practitioners can look forward to an engaging virtual exhibit hall, scientific poster session, and the unparalleled level of expertise and education practitioners have come to expect from PAINWeek.

Debra Weiner, Executive Vice President, Program Development, remarked, “While the last several months have been challenging, they have also provided an opportunity to expand the availability of continuing medical education in pain management. Barriers to care have been exacerbated by our current pandemic.”

“The need for pain education is not on hiatus,” said senior faculty member Kevin Zacharoff, MD, FACIP, FACPE, FAAP. “Patients need us now more than ever to help them negotiate pain and suffering. This year, the virtual PAINWeek will help attendees familiarize themselves with what the largest multidisciplinary pain conference in the country has to offer—in September and for the rest of the year.” Dr. Zacharoff is Clinical Instructor and Course Director, Pain and Addiction, at the Renaissance School of Medicine at Stony Brook University. He will present two courses: Who Will Love this Child? Advocating for Chronic Pain Patients; and Triple Threat or Epiphany? The Need for a Biopsychosocial Approach to Pain Management.

Over three days, PAINWeek will provide an expansive, multidisciplinary curriculum of 75 CE/CME hours presented by current and emerging thought leaders. An additional 45 hours of certified content will be provided as an enduring, on demand activity for a total of 120 hours.

The International Pelvic Pain Society (IPPS) will be presenting at PAINWeek 2020. “This is the 5th consecutive year of PAINWeek and IPPS collaborating in educating healthcare providers about the complexities surrounding chronic pelvic pain (CPP) conditions in women,” commented Jorge F. Carrillo, MD, a Director on the Board of the IPPS. He will present The Evil Quintuplets: Endometriosis and Other Chronic Pelvic Pain Etiologies. “For the IPPS, it is a privilege to be able to support a program discussing up-to-date topics, bringing awareness and providing helpful clinical tools to assess and treat CPP patients. This year we will discuss trauma informed care approaches and common chronic overlapping pain conditions associated with CPP such as endometriosis, myofascial pain disorders, and bladder pain syndrome.” Other IPPS courses include The First Encounter: A Trauma Informed Care Application; Where East Meets West: Using an Integrative Approach to Treating Overlapping Pelvic Pain Disorders; and Twisted Sister: Musculoskeletal Causes of Chronic Pelvic Pain.

To learn more about PAINWeek or to register for the conference, click here, visit painweek.org, or call (973) 415-5100.

About Global Education Group:

Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.

Share article on social media or email: